sam altman merge labs - Search News

News

Sam Altman, Neuralink and Gene Therapy

Bloomberg · 2h

Sam Altman’s Brain Chip Venture Is Mulling Gene Therapy Approach

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring the idea of genetically altering brain cells to make better implants. The company,

Seeking Alpha on MSN · 1h

Sam Altman’s rival to Neuralink reportedly eying gene therapy technology

A novel gene therapy idea is reportedly among the focus areas considered by Merge Labs, a new brain-computer interface startup positioned by its backers, including Sam Altman and his AI firm OpenAI, as a potential rival to Tesla (TSLA) CEO Elon Musk’s neurotechnology company Neuralink.

Yahoo Finance · 1d

Sam Altman To Back Merge Labs, Neuralink Rival

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the Financial Times reported.

1d

What is Merge Labs? The New Brain-Computer Startup Backed by OpenAI Challenging Elon Musk's Neuralink

Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

OpenAI is reportedly backing new BCI venture Merge Labs

The Financial Times reports today that OpenAI co-founder Sam Altman plans to invest in new brain-computer interface (BCI) venture Merge Labs.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results